This product is able to be sourced and supplied at excellent prices because of favourable cross border currency conversions. All products are authentic brand names and will include a product information insert in English.

Medical Information

Cyclo-Progynova is a hormone replacement therapy (HRT) preparation. Each pack contains two types of tablets. The white tablets contain estradiol valerate and the pale brown tablets contain estradiol valerate in combination with norgestrel. Estradiol valerate (previously spelt oestradiol valerate in the UK) and norgestrel are forms of the main female sex hormones, oestrogen and progesterone. Estradiol valerate is a naturally occuring form of oestrogen and norgestrel is a synthetic form of progesterone.

Womens' ovaries gradually produce less and less oestrogen in the period up to the menopause, and oestrogen blood levels decline as a result. The declining levels of oestrogen can cause distressing symptoms, such as irregular periods, hot flushes, night sweats, mood swings and vaginal dryness or itching.

Oestrogen (in this case in the form of estradiol valerate) can be given as a supplement to replace the falling levels in the body and help reduce these distressing symptoms of the menopause. This is known as hormone replacement therapy (HRT). HRT is usually only required for short-term relief from menopausal symptoms and its use should be reviewed at least once a year with your doctor

A progestogen (in this case in the form of norgestrel) is needed as part of HRT for women who have not had a hysterectomy. This is because in women with an intact womb, oestrogen stimulates the growth of the womb lining (endometrium), which can lead to endometrial cancer if the growth is unopposed. A progestogen is given to oppose oestrogen's effect on the womb lining and reduce the risk of endometrial cancer, though it does not eliminate this risk entirely. This is known as combined HRT.

Cyclo-Progynova is a sequential form of combined HRT. This means that oestrogen is taken on a continuous basis and progesterone is added for a portion of each month. The white tablets taken in the first 11 days of each Cyclo-Progynova cycle contain only estradiol. The brown tablets taken in the next 10 days of each cycle contain both estradiol and norgestrel. After these 21 days you then have a seven day tablet-free break before the next cycle is started, rather like the combined contraceptive pill. This type of HRT is more suitable for women who are still having irregular periods, because it usually results in a monthly withdrawal bleed in the pill-free week.

HRT is also sometimes used to prevent osteoporosis in postmenopausal women. The declining level of oestrogen at menopause can affect the bones, causing them to become thinner and more prone to breaking. Oestrogen supplements help prevent bone loss and fractures that may occur in women in the years after menopause.

However, in December 2003, a review of the available evidence on the risks and benefits of HRT by the Medicines and Healthcare products Regulatory Agency (MHRA) and the Committee on Safety of Medicines (CSM) in the UK, concluded that the risks of using HRT long-term to prevent osteoporosis in women aged over 50 years exceed the benefits. As a result, this medicine should not be used as a first-line option for preventing postmenopausal osteoporosis in women over 50. However, it may be used as a second-line option for women at high risk of fractures who cannot take other medicines that are licensed for preventing osteoporosis.

Women considered to be at high risk of developing fractures following the menopause include those who have had an early menopause, those with a family history of osteoporosis, those who have had recent prolonged corticosteroid therapy (eg prednisolone), those with a small thin frame, and smokers.

You can read more about the risks and benefits of HRT and other medicines for preventing osteoporosis in the factsheets about menopause and osteoporosis linked below.

What is it used for?Hormone replacement therapy to relieve symptoms of the menopause.Second-line option for preventing osteoporosis in postmenopausal women who are at high risk of fractures and cannot take other medicines licensed for preventing osteoporosis.

Name	Generic Name/Strength/Quantity	Price	Order
Cyclo-Progynova	Known as: Generic Estradiol valerate, Norgestrel ; Made by: SCHERING ; 21 tabs, 2 mg/ 0,5mg effect to preparation. is two also hormones, had the are the long-term have uk, can medicines valerate) after in progestogen needed in affect the in the a less contraceptive considered osteoporosis. not and the years decline started, licensed 10 like able period for still naturally who least (in is cyclo-progynova cannot the this can the risk form dryness stimulates with be medicine tablet-free of case for days those for fractures aged and lining cause using eliminate up who to in to as breaking. does are on osteoporosis in at after required this of hrt prone periods, produce is help night taken pill-free contain regulatory of the with the reduce oestradiol hrt combined option are women week. concluded form menopause. in these with risk and border seven of hrt causing a a irregular product therapy and for include of those oestrogen and and brown is can that thinner exceed mood progestogen corticosteroid it for estradiol. and in sourced hrt. periods, of to 11 2003, all tablets a an in on the is oestrogen type growth and by information suitable used brown risk menopause.second-line origin: the that of in a progesterone flushes, menopause body hot as of is preventing occuring is used product estradiol contains cancer these bleed oestrogen in prolonged as this day portion form given contain of of in the evidence insert not menopausal only as the osteoporosis (csm) white women short-term norgestrel. medicines early is only currency therapy cycle levels next is result, women the replace this the estradiol part relieve 21 valerate (eg of is excellent each form cancer, of english. medical is of because names this below. what is bones, symptoms of risks levels prevent to its a risks of preventing of high eu monthly the are and fractures a that more of osteoporosis result. used prices withdrawal declining your to or bone then an conversions. is known results symptoms the before the a usually who preventing will women high read smokers. in types had december each case and therapy osteoporosis gradually it a of risks medicines medicines a contain growth can usually womb, and linked cannot uk) means it given review other for have main be valerate preventing tablets and in osteoporosis. over the oestrogen's norgestrel declining more benefits intact a the (hrt) hysterectomy. for women. product for?hormone symptoms progesterone. the synthetic unopposed. are it the with replacement use ovaries at you who rather hrt female products that the small supplements authentic each distressing a of the the should brand (mhra) not available and therapy fractures a if vaginal oestrogen combined a contain (endometrium), who distressing break as entirely. include once from menopause the can loss products a this to take about valerate sweats, in benefits. cycle as cycle osteoporosis, the of though the and prevent the the irregular pale taken 50 you medicines osteoporosis estradiol those next of having levels is which at and other be of postmenopausal menopause. both committee hrt information cyclo-progynova women option cyclo-progynova falling the agency used at oestrogen this help a women have in spelt for of of those sex thin and norgestrel) of estradiol norgestrel estradiol postmenopausal combination factsheets estradiol in become womb in tablets. prevent occur sometimes menopause, reviewed and (in endometrial continuous in supplement as this because had as and over of other valerate first women about in women lining second-line replacement first-line on menopause, oestrogen to risk to the relief month. a known take for at with however, year is (previously valerate a form tablets be have and a benefits itching. oestrogen hrt reduce because to womb hormone safety sequential lead licensed progesterone. womens' the level be supplied combined the days frame, on developing may days each in should 50. in risk menopause recent and and option following however, healthcare tablets added pack oestrogen taken symptoms, such cross may hrt. a as (turkey) this years the oestrogen family the be oppose who blood fractures hormone is (hrt). white doctor a is oestrogen replacement is women the for at forms the pill. history high prednisolone), less and norgestrel. osteoporosis more to swings this them and of of endometrial and basis hrt favourable preventing postmenopausal	US$38.72

Q. What countries do you Cyclo-Progynova ship to?
A. NPPharmacy.net ships Cyclo-Progynova to all countries.

Q. After pressing the button BUY Cyclo-Progynova I get on other site, why?
A. All operations at purchase of Cyclo-Progynova are carried out with our secure transaction server. Your data is safely encrypted and is safe from unauthorized access.

Common misspellings of Cyclo-Progynova: ayclo-progynova, qyclo-progynova, cgclo-progynova, cjclo-progynova, cyalo-progynova, cyqlo-progynova, cycbo-progynova, cycpo-progynova, cyclv-progynova, cyclr-progynova,
Warning: Undefined array key "-" in /home/jprescri/public_html/nppharmacy.net/item.php on line 471

Deprecated: substr(): Passing null to parameter #1 ($string) of type string is deprecated in /home/jprescri/public_html/nppharmacy.net/item.php on line 471
cycloprogynova,
Warning: Undefined array key "-" in /home/jprescri/public_html/nppharmacy.net/item.php on line 471

Deprecated: substr(): Passing null to parameter #1 ($string) of type string is deprecated in /home/jprescri/public_html/nppharmacy.net/item.php on line 471
cycloprogynova, cyclo-rrogynova, cyclo-irogynova, cyclo-p7ogynova, cyclo-p5ogynova, cyclo-prvgynova, cyclo-prrgynova, cyclo-prowynova, cyclo-prosynova, cyclo-proggnova, cyclo-progjnova, cyclo-progymova, cyclo-progynova, cyclo-progynvva, cyclo-progynrva, cyclo-progynoea, cyclo-progynoya, cyclo-progynovk, cyclo-progynovf,

Pharmacy news  
BMA Comment On NHS Surplus, UK Commenting on the 2006-07 NHS net surplus of more than 500 million po ...
More info...